PremiumCompany AnnouncementsPfizer Targets Cancer-Related Weight Loss With New Ponsegromab Study2d agoPFE
PremiumCompany AnnouncementsPfizer’s RSV Revaccination Trial Targets Durable Booster Revenue in High‑Risk Adults2d agoPFE
PremiumThe FlyBristol Myers reports results from prespecified analysis of EXCALIBER-RRMM trial2d agoBMY
PremiumBlurbsAnalysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME) and Merck & Company (MRK)2d agoMRKPRME
Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME) and Merck & Company (MRK)